DOP106: Geographic disparities in Healthcare Utilisation in people with inflammatory bowel disease, Crohn’s Colitis Cure Data Insights ProgramECCO'25 Berlin
2025
DOP108: Inflammatory Bowel Disease and concomitant endometriosis: frequency and characteristics in a multidisciplinary approachECCO'25 Berlin
2025
DOP109: A necroptotic-to-apoptotic signaling axis underlies inflammatory bowel diseaseECCO'25 Berlin
2025
DOP110: Optimized inflammatory and ER stress-induced phenotypes in differentiated intestinal organoids for modelling Inflammatory Bowel DiseaseECCO'25 Berlin
2025
DOP111: Lack of epithelial RhoA in the gut, a new colitis-associated cancer experimental model.ECCO'25 Berlin
2025
DOP112: Inflammation-associated monocytes express ACOD1 to curtail inflammatory behaviour in IBD and experimental colitisECCO'25 Berlin
2025
DOP114: LDN-071, the novel amino acid-based PAI-1 inhibitor, significantly reduces the severity of acute and chronic inflammation in colitis modelsECCO'25 Berlin
2025
DOP115: Exophiala dermatitidis aggravates colitis through the Syk-CARD9 signaling pathwayECCO'25 Berlin
2025
DOP116: Preclinical characterization of IMU-856, an orally available epigenetic modulator of gut barrier function and regenerationECCO'25 Berlin
2025
DOP117: Innate lymphoid cells control colitis and intestinal fibrosis via cellular stress response in mice and humanECCO'25 Berlin
2025
DOP119: Predicting response to anti-tumour necrosis factor-alpha therapy-α in fibrostenotic Crohn’s disease using infra-red microspectroscopyECCO'25 Berlin
2025
DOP120: Low-intensity Pulsed Ultrasound Modulates Metabolite Release Reflecting the Inflammatory Status of Colonic MucosaECCO'25 Berlin
2025
DOP121: Distinct tryptophan metabotypes associate with disease activity, treatment escalation and future disease progression in Inflammatory Bowel DiseaseECCO'25 Berlin
2025